Interesting
Cochrane international reference reports only 2 Human studies that are relevant. Awaiting the peer reviewed paper on UK NHS Ashford and St Peter’s placebo study
If Viraleze 7 day treatment is competing with Paxlovid - who wins, page-2
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.50M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.0¢ | 12.0¢ | $51.94K | 417.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 419808 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 6519 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.5¢ |
Change
0.000 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 12.0¢ | 13.0¢ | 12.0¢ | 212430 | ||
| Last updated 15.59pm 09/05/2024 ? | |||||
| SPL (ASX) Chart |